[Nucleodoxin in the treatment of alcoholic myocardiopathies. Hemodynamic evaluations with the polygraphic method].
D000249:Adenosine Monophosphate / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000437:Alcoholism / Q000150:complications* / Q000188:drug therapy; D002318:Cardiovascular Diseases / Q000188:drug therapy*; D006331:Heart Diseases / Q000188:drug therapy* / Q000209:etiology; D006334:Heart Function Tests; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy; D008297:Male; D008722:Methods; D008875:Middle Aged; D009711:Nucleotides / Q000627:therapeutic use*; D011736:Pyridoxine / Q000627:therapeutic use*; D013654:Taurine / Q000627:therapeutic use*; D014500:Uracil Nucleotides / Q000627:therapeutic use; D014805:Vitamin B 12 / Q000627:therapeutic use*
D009711:Nucleotides; D014500:Uracil Nucleotides; D013654:Taurine; D000249:Adenosine Monophosphate; D011736:Pyridoxine; D014805:Vitamin B 12
La nucleodoxina nel trattamento della miocardiopatia alcolica. Valutazioni emodinamiche con metodo poligrafico.